Albuterol has been proven to be a vital component in the management of severe, acute asthma in children and adults. Continuous nebulization of albuterol is a relatively new administration technique for treating patients with unresponsive asthma. This method may offer the advantages of greater penetration of drug into the lung, reduced bronchospasm, and a more rapid and sustained response. In clinical trials, continuous nebulization has been shown to be as effective as intermittent nebulization and may be associated with a reduction in the need for hospital admission, length of hospital stay, and the use of mechanical ventilation. Adverse effects observed with albuterol use, including tremor, metabolic disturbances, and cardiotoxicity, are rare and appear to be no more prevalent with the continuous method of nebulization
Skip Nav Destination
Respiratory Pharmacology| May 01 1995
Administration of Albuterol by Continuous Nebulization
Marcia L. Buck, PharmD
From the Schools of Medicine and Nursing, University of Virginia, Charlottesville, Virginia.
Reprint requests to Marcia L. Buck, PharmD, Box 274-11, University of Virginia Medical Center, Charlottesville, VA 22908.
Search for other works by this author on:
AACN Adv Crit Care (1995) 6 (2): 279–286.
Marcia L. Buck; Administration of Albuterol by Continuous Nebulization. AACN Adv Crit Care 1 May 1995; 6 (2): 279–286. doi:
Download citation file:
Don't already have an account? Register
AACN AccountSign In
Sign in via your InstitutionSign in via your Institution
Subscribe online and gain access to the entire archive.
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access